If someone told you to get an eye exam, would you associate that with a virtual reality headset? It might be where ophthalmology diagnostics will end up in the near future. Compared to the existing diagnostics tools, a VR approach is much more portable and hence accessible. The Swiss company PeriVision is using AI and VR to enable more efficient workflows and deeper clinical insights to manage eye diseases better. I spoke with the co-founder and CEO of Perivision, Patrick Kessel. Prior to joining PeriVision, Patrick advised Medtech, biopharma, and insurance clients on business development, go-to-market strategy, digitization, and operations optimization at the Boston Consulting Group (BCG). We discussed how VR and AI help in eye care, what the competition is in the field, and how did the company evolve. Perivison won EIT Health’s Wild Card program in 2021 and received 1.5 million euros for its further development. Patrick shared his reflection on the wild card program and which startups the program is most suitable for. 

*****

This episode is supported by EIT held in Germany, Switzerland, which is one of the eight knowledge and innovation communities currently funded by the European Institute of Innovation and technology. EIT Health Germany-Switzerland is currently serving 26 leading companies and public health care institutions in Germany and Switzerland, as well as renowned universities and research institutions, to realize EIT Health’s mission of a public-private partnership. To learn more, visit https://eit-health.de/, where you will find more about innovation, acceleration, and education programs.